Insulin cessation and diabetes remission after bariatric surgery in adults with insulin-treated type 2 diabetes

Diabetes Care

Volumn 38, Issue 4, 2015, Pages 659-664

  Ardestani, Ali ^a   Rhoads, David ^b   Tavakkoli, Ali ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; GASTRIC BANDING; GLUCOSE HOMEOSTASIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; REMISSION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; WEIGHT REDUCTION; AGED; BODY WEIGHT; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; LONGITUDINAL STUDY; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; BARIATRIC SURGERY; BODY WEIGHT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REMISSION INDUCTION; WEIGHT LOSS; WITHHOLDING TREATMENT;

EID: 84942775364     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-1751     Document Type: Article

References (33)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311-321.
2. Gregg EW, Chen H, Wagenknecht LE, et al.; Look AHEAD Research Group. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012;308: 2489-2496.
3. Pontiroli AE, Folli F, Paganelli M, et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: A 4-year casecontrolled study. Diabetes Care 2005;28:2703- 2709.
4. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577-1585.
5. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222:339-350; discussion 350-352.
6. Carlsson LMS, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012; 367:695-704.
7. Dixon JB, Zimmet P, Alberti KG, Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: An IDF statement for obese type 2 diabetes. Surg Obes Relat Dis 2011;7:433-447.
8. Dorman RB, Serrot FJ, Miller CJ, et al. Casematched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient. Ann Surg 2012;255:287-293.
9. Schauer PR, Bhatt DL, Kirwan JP, et al.; STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetesd3-year outcomes. N Engl J Med 2014;370:2002- 2013.
10. DeMaria EJ, Pate V, Warthen M, Winegar DA. Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2010;6:347-355.
11. DeMaria EJ, Winegar DA, Pate VW, Hutcher NE, Ponce J, Pories WJ. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg 2010;252:559-566; discussion 566-567.
12. Inabnet WB 3rd, Winegar DA, Sherif B, Sarr MG. Early outcomes of bariatric surgery in patients with metabolic syndrome: An analysis of the bariatric outcomes longitudinal database. J Am Coll Surg 2012;214:550-556; discussion 556-557.
13. Ali MR, Maguire MB, Wolfe BM. Assessment of obesity-related comorbidities: A novel scheme for evaluating bariatric surgical patients. J Am Coll Surg 2006;202:70-77.
14. Oria HE, Carrasquilla C, Cunningham P, et al.; American Society for Bariatric Surgery Standards Committee, 2004-2005. Guidelines for weight calculations and follow-up in bariatric surgery. Surg Obes Relat Dis 2005;1:67-68.
15. Belle SH, Berk PD, Courcoulas AP, et al.; LABS Consortium Weight Change Writing Group. Reporting weight change: standardized reporting accounting for baseline weight. Surg Obes Relat Dis 2013;9:782-789.
16. Metropolitan Life Insurance Company. Metropolitan height and weight tables. Stat Bull Metropol Life Insur Co. 1983;64:2-9.
17. Blackwell M, Iacus S, King G, Porro G. CEM: Coarsened Exact Matching in Stata. Stata J 2009; 9:524-546.
18. Stuart EA. Matching methods for causal inference: A review and a look forward. Stat Sci 2010;25:1-21.
19. Hamza N, Abbas MH, Darwish A, Shafeek Z, NewJ, Ammori BJ. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis 2011;7:691-696.
20. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003;237:751-756; discussion 757-758.
21. Kim S, Richards WO. Long-term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after Roux-en-Y gastric bypass. Ann Surg 2010;251:1049-1055.
22. Casella G, Abbatini F, Cali B, Capoccia D, Leonetti F, Basso N. Ten-year duration of type 2 diabetes as prognostic factor for remission after sleeve gastrectomy. Surg Obes Relat Dis 2011;7:697-702.
23. Centers for Disease Control and Prevention. Age-adjusted percentage of adults with diabetes using diabetes medication, by type of medication, United States, 1997-2011 [article online], 2012. Available from http://www.cdc.gov/diabetes/statistics/meduse/fig2.htm. Accessed 24 November 2014.
24. Geller AI, Shehab N, Lovegrove MC, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med 2014;174:678-686.
25. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238: 467-484; discussion 84-85.
26. Singhal R, Ahmed M, Krempic A, Kitchen M, Super P. Medium-term outcomes of patients with insulin-dependent diabetes after laparoscopic adjustable gastric banding. Surg Obes Relat Dis 2013;9:42-47.
27. Busetto L, Sbraccia P, Frittitta L, Pontiroli AE. The growing role of bariatric surgery in the management of type 2 diabetes: evidences and open questions. Obes Surg 2011;21:1451-1457.
28. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248-256.
29. Kadera BE, Lum K, Grant J, Pryor AD, Portenier DD, DeMaria EJ. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss. Surg Obes Relat Dis 2009;5:305-309.
30. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004; 240:236-242.
31. Pournaras DJ, Osborne A, Hawkins SC, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg 2010;252:966-971.
32. Stearns ATBATA, Balakrishnan A, Tavakkolizadeh A. Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport. Am J Physiol Gastrointest Liver Physiol 2009;297:G950-G957.
33. Knop FK, Taylor R. Mechanism of metabolic advantages after bariatric surgery: it's all gastrointestinal factors versus it's all food restriction. Diabetes Care 2013;36(Suppl.2):S287-S291.